Our previous work showed that AP-2β induces expression of KCTD1 that functions as a repressor of β-catenin signaling and that mice lacking KCTD1 develop progressive DCT defects and renal fibrosis accompanied by β-catenin hyperactivation and downstream profibrogenic mTOR activation17. The gene discussed is KCTD1; the disease is renal fibrosis.